SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1v10'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1D0V_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 8 GLY A 277
GLY A 179
LEU A 190
GLY A 188
 None
 0.75A 1d0vA-1v10A:
undetectable		 1d0vA-1v10A:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E9Y_B_HAEB800_1
(UREASE SUBUNIT BETA)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 451
HIS A 109
HIS A  64
HIS A 401
 CU  A1501 (-2.9A)
CU  A1500 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
 0.97A 1e9yB-1v10A:
undetectable		 1e9yB-1v10A:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1G50_B_ESTB1600_1
(ESTROGEN RECEPTOR)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 12 LEU A 120
LEU A  10
LEU A  52
ILE A  87
LEU A   7
 None
 1.23A 1g50B-1v10A:
undetectable		 1g50B-1v10A:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1G50_C_ESTC2600_1
(ESTROGEN RECEPTOR)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 11 LEU A 120
LEU A  10
LEU A  52
ILE A  87
LEU A   7
 None
 1.22A 1g50C-1v10A:
undetectable		 1g50C-1v10A:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JHA_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 8 GLY A 277
GLY A 179
LEU A 190
GLY A 188
 None
 0.76A 1jhaA-1v10A:
undetectable		 1jhaA-1v10A:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JHQ_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 8 GLY A 277
GLY A 179
LEU A 190
GLY A 188
 None
 0.75A 1jhqA-1v10A:
undetectable		 1jhqA-1v10A:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JHV_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 8 GLY A 277
GLY A 179
LEU A 190
GLY A 188
 None
 0.74A 1jhvA-1v10A:
undetectable		 1jhvA-1v10A:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NOD_B_H4BB902_1
(NITRIC OXIDE
SYNTHASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ARG A 121
ILE A 454
TRP A 456
 None
CU  A1503 (-3.4A)
None
 0.87A 1nodB-1v10A:
undetectable		 1nodB-1v10A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PCG_A_ESTA1_1
(ESTROGEN RECEPTOR)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 10 LEU A 120
LEU A  10
LEU A  52
ILE A  87
LEU A   7
 None
 1.25A 1pcgA-1v10A:
undetectable		 1pcgA-1v10A:
17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QOM_A_H4BA902_1
(NITRIC OXIDE
SYNTHASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ARG A 121
ILE A 454
TRP A 456
 None
CU  A1503 (-3.4A)
None
 1.06A 1qomA-1v10A:
undetectable		 1qomA-1v10A:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DTJ_A_THRA401_0
(ASPARTOKINASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 8 GLY A 446
GLU A 468
ALA A 467
ILE A 470
 None
 0.76A 2dtjA-1v10A:
undetectable
2dtjB-1v10A:
undetectable		 2dtjA-1v10A:
16.00
2dtjB-1v10A:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.26A 2fqeA-1v10A:
32.4		 2fqeA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.29A 2fqeA-1v10A:
32.4		 2fqeA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.84A 2fqeA-1v10A:
32.4		 2fqeA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.24A 2fqfA-1v10A:
32.3		 2fqfA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.33A 2fqfA-1v10A:
32.3		 2fqfA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.81A 2fqfA-1v10A:
32.3		 2fqfA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.21A 2fqgA-1v10A:
32.4		 2fqgA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.36A 2fqgA-1v10A:
32.4		 2fqgA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.80A 2fqgA-1v10A:
32.4		 2fqgA-1v10A:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NOD_B_H4BB902_1
(NITRIC OXIDE
SYNTHASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ARG A 121
ILE A 454
TRP A 456
 None
CU  A1503 (-3.4A)
None
 0.86A 2nodB-1v10A:
undetectable		 2nodB-1v10A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OPX_A_DXCA1003_0
(ALDEHYDE
DEHYDROGENASE A)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 ILE A 345
LEU A 332
ALA A 463
PHE A 438
 None
 0.70A 2opxA-1v10A:
undetectable		 2opxA-1v10A:
20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VE3_B_REAB1445_1
(PUTATIVE CYTOCHROME
P450 120)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 12 THR A 242
PHE A 244
ALA A 307
THR A 410
GLY A 430
 None
 1.27A 2ve3B-1v10A:
undetectable		 2ve3B-1v10A:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WKO_A_CUA154_0
(SUPEROXIDE DISMUTASE
[CU-ZN])		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A 111
HIS A 109
HIS A 401
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1500 (-3.3A)
CU  A1501 ( 3.2A)
 1.00A 2wkoA-1v10A:
undetectable		 2wkoA-1v10A:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_2
(ANGIOTENSIN
CONVERTING ENZYME)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 SER A 379
THR A 442
PHE A 438
 None
 0.64A 2x91A-1v10A:
0.0		 2x91A-1v10A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKK_E_MFXE1100_1
(TOPOISOMERASE IV
DNA)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ARG A 121
GLU A 459
SER A 207
 None
 0.80A 2xkkA-1v10A:
undetectable
2xkkC-1v10A:
undetectable		 2xkkA-1v10A:
21.76
2xkkC-1v10A:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E7I_B_H4BB2902_1
(NITRIC OXIDE
SYNTHASE, INDUCIBLE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ARG A 121
ILE A 454
TRP A 456
 None
CU  A1503 (-3.4A)
None
 0.98A 3e7iB-1v10A:
undetectable		 3e7iB-1v10A:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NV6_A_CAMA422_0
(CYTOCHROME P450)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 GLY A 122
ILE A 146
VAL A 145
 None
 0.50A 3nv6A-1v10A:
undetectable		 3nv6A-1v10A:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NW2_A_H4BA902_1
(NITRIC OXIDE
SYNTHASE, INDUCIBLE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ARG A 121
ILE A 454
TRP A 456
 None
CU  A1503 (-3.4A)
None
 1.00A 3nw2A-1v10A:
undetectable		 3nw2A-1v10A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NW2_B_H4BB902_1
(NITRIC OXIDE
SYNTHASE, INDUCIBLE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ARG A 121
ILE A 454
TRP A 456
 None
CU  A1503 (-3.4A)
None
 0.97A 3nw2B-1v10A:
undetectable		 3nw2B-1v10A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O1C_A_ADNA127_1
(HISTIDINE TRIAD
NUCLEOTIDE-BINDING
PROTEIN 1)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 10 ILE A 334
ILE A 345
ILE A 429
SER A 428
HIS A 457
 None
None
None
None
CU  A1503 (-3.2A)
 1.14A 3o1cA-1v10A:
undetectable		 3o1cA-1v10A:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O1C_A_ADNA127_1
(HISTIDINE TRIAD
NUCLEOTIDE-BINDING
PROTEIN 1)		 1v10 LACCASE
(Rigidoporus
microporus) 		6 / 10 ILE A 386
PHE A 440
ILE A 388
ILE A 378
SER A 379
HIS A 403
 None
 1.49A 3o1cA-1v10A:
undetectable		 3o1cA-1v10A:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O1C_A_ADNA127_1
(HISTIDINE TRIAD
NUCLEOTIDE-BINDING
PROTEIN 1)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 10 ILE A 386
PHE A 440
ILE A 388
LEU A 400
HIS A 403
 None
 1.19A 3o1cA-1v10A:
undetectable		 3o1cA-1v10A:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O1X_A_ADNA1450_1
(HISTIDINE TRIAD
NUCLEOTIDE-BINDING
PROTEIN 1)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 10 ILE A 386
PHE A 440
ILE A 388
ILE A 378
HIS A 403
 None
 1.03A 3o1xA-1v10A:
undetectable		 3o1xA-1v10A:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O1X_A_ADNA1450_1
(HISTIDINE TRIAD
NUCLEOTIDE-BINDING
PROTEIN 1)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 10 ILE A 386
PHE A 440
ILE A 388
LEU A 400
HIS A 403
 None
 1.19A 3o1xA-1v10A:
undetectable		 3o1xA-1v10A:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGZ_A_ADNA127_1
(HISTIDINE TRIAD
NUCLEOTIDE-BINDING
PROTEIN 1)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 10 ILE A 386
PHE A 440
ILE A 388
ILE A 378
HIS A 403
 None
 0.95A 3qgzA-1v10A:
undetectable		 3qgzA-1v10A:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QGZ_A_ADNA127_1
(HISTIDINE TRIAD
NUCLEOTIDE-BINDING
PROTEIN 1)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 10 ILE A 386
PHE A 440
ILE A 388
LEU A 400
HIS A 403
 None
 1.19A 3qgzA-1v10A:
undetectable		 3qgzA-1v10A:
13.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA601_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 396
CYH A 452
ILE A 454
HIS A 457
LEU A 462
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
None
 0.34A 3qpkA-1v10A:
42.3		 3qpkA-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA602_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 HIS A 111
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.27A 3qpkA-1v10A:
42.3		 3qpkA-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA603_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.26A 3qpkA-1v10A:
42.3		 3qpkA-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.28A 3qpkA-1v10A:
42.3		 3qpkA-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.32A 3qpkA-1v10A:
42.3		 3qpkA-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.86A 3qpkA-1v10A:
42.3		 3qpkA-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB601_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.31A 3qpkB-1v10A:
42.3		 3qpkB-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB602_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 HIS A 111
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.24A 3qpkB-1v10A:
42.3		 3qpkB-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB603_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.22A 3qpkB-1v10A:
42.4		 3qpkB-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.22A 3qpkB-1v10A:
42.4		 3qpkB-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.26A 3qpkB-1v10A:
42.4		 3qpkB-1v10A:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.84A 3qpkB-1v10A:
42.4		 3qpkB-1v10A:
32.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RV5_A_DXCA91_0
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 PHE A  97
GLN A  84
PHE A 124
 None
 0.82A 3rv5A-1v10A:
undetectable		 3rv5A-1v10A:
9.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_E_CLME221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 PHE A 343
CYH A 452
HIS A 457
 None
CU  A1503 (-2.1A)
CU  A1503 (-3.2A)
 0.92A 3u9fF-1v10A:
undetectable		 3u9fF-1v10A:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_I_CLMI221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 PHE A 343
CYH A 452
HIS A 457
 None
CU  A1503 (-2.1A)
CU  A1503 (-3.2A)
 0.88A 3u9fG-1v10A:
undetectable		 3u9fG-1v10A:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_R_CLMR221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 PHE A 343
CYH A 452
HIS A 457
 None
CU  A1503 (-2.1A)
CU  A1503 (-3.2A)
 0.82A 3u9fS-1v10A:
undetectable		 3u9fS-1v10A:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  66
HIS A 109
HIS A 399
HIS A 453
 CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
 0.23A 4ef3A-1v10A:
32.2		 4ef3A-1v10A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 401
HIS A 451
HIS A  64
HIS A 111
 CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
 0.71A 4ef3A-1v10A:
32.2		 4ef3A-1v10A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.33A 4ef3A-1v10A:
32.2		 4ef3A-1v10A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 399
HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.58A 4ef3A-1v10A:
32.2		 4ef3A-1v10A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.23A 4ef3A-1v10A:
32.3		 4ef3A-1v10A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.33A 4ef3A-1v10A:
32.3		 4ef3A-1v10A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.83A 4ef3A-1v10A:
32.3		 4ef3A-1v10A:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MK4_B_CHDB502_0
(FERROCHELATASE,
MITOCHONDRIAL)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 6 PHE A 216
MET A 223
ILE A 205
VAL A 193
 None
 1.30A 4mk4B-1v10A:
undetectable		 4mk4B-1v10A:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U15_A_0HKA2001_1
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 12 SER A 113
THR A 339
THR A 340
ALA A 341
ALA A 460
 None
 1.46A 4u15A-1v10A:
undetectable		 4u15A-1v10A:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CU6_A_ACTA403_0
(CASEIN KINASE II
SUBUNIT ALPHA)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 6 VAL A 126
ASP A 128
PRO A 129
ALA A 103
 None
 0.84A 5cu6A-1v10A:
undetectable		 5cu6A-1v10A:
19.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.26A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 399
HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.57A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 451
HIS A 399
HIS A 111
HIS A 401
HIS A  64
 CU  A1501 (-2.9A)
CU  A1502 (-2.9A)
CU  A1501 (-3.3A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
 1.44A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		6 / 6 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 399
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
 0.17A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 6 HIS A  64
HIS A 111
HIS A 399
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
 0.70A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 6 HIS A 399
HIS A 401
HIS A 451
HIS A  64
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
 0.63A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.19A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.26A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA504_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.30A 5mejA-1v10A:
61.3		 5mejA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.26A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 399
HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.55A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 451
HIS A 399
HIS A 111
HIS A 401
HIS A  64
 CU  A1501 (-2.9A)
CU  A1502 (-2.9A)
CU  A1501 (-3.3A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
 1.44A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		6 / 6 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 399
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
 0.16A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 6 HIS A  64
HIS A 111
HIS A 399
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
 0.69A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 6 HIS A 399
HIS A 401
HIS A 451
HIS A  64
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
 0.63A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.20A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.26A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA504_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.28A 5mewA-1v10A:
61.3		 5mewA-1v10A:
60.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 111
HIS A  64
HIS A 453
HIS A 109
HIS A  66
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1500 (-3.4A)
CU  A1500 (-3.3A)
CU  A1500 ( 2.9A)
 1.42A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 399
HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.56A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 451
HIS A 399
HIS A 111
HIS A 401
HIS A  64
 CU  A1501 (-2.9A)
CU  A1502 (-2.9A)
CU  A1501 (-3.3A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
 1.44A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		6 / 6 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 399
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
 0.16A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 6 HIS A  64
HIS A 111
HIS A 399
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
 0.70A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 6 HIS A 399
HIS A 401
HIS A 451
HIS A  64
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
 0.63A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.19A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.28A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA504_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.26A 5mhuA-1v10A:
61.3		 5mhuA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.24A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 111
HIS A  64
HIS A 453
HIS A 109
HIS A  66
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1500 (-3.4A)
CU  A1500 (-3.3A)
CU  A1500 ( 2.9A)
 1.42A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 399
HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.56A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A 451
HIS A 399
HIS A 111
HIS A 401
HIS A  64
 CU  A1501 (-2.9A)
CU  A1502 (-2.9A)
CU  A1501 (-3.3A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
 1.44A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		6 / 6 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 399
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1502 (-2.9A)
CU  A1500 (-3.4A)
 0.16A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 6 HIS A  64
HIS A 111
HIS A 399
HIS A 451
 CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
 0.70A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 6 HIS A 399
HIS A 401
HIS A 451
HIS A  64
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1502 (-3.2A)
CU  A1501 (-3.3A)
 0.64A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.19A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.28A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA504_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.25A 5mhvA-1v10A:
61.3		 5mhvA-1v10A:
60.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.61A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.17A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.91A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.28A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.25A 5mhwA-1v10A:
61.3		 5mhwA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.90A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.28A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.25A 5mhxA-1v10A:
61.3		 5mhxA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.91A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.29A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.25A 5mhyA-1v10A:
61.3		 5mhyA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.61A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.91A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.19A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.29A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.24A 5mhzA-1v10A:
61.4		 5mhzA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.90A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.29A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.25A 5mi1A-1v10A:
61.3		 5mi1A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.24A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.90A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.29A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.24A 5mi2A-1v10A:
61.4		 5mi2A-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.90A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.30A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.24A 5miaA-1v10A:
61.4		 5miaA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.90A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.30A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.24A 5mibA-1v10A:
61.3		 5mibA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.25A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.91A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.30A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.24A 5micA-1v10A:
61.4		 5micA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.24A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.91A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.29A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.24A 5midA-1v10A:
61.4		 5midA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A 399
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.24A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 453
HIS A  64
HIS A  66
HIS A 109
 CU  A1500 (-3.4A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-3.3A)
 0.62A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.18A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.91A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.18A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.30A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.24A 5mieA-1v10A:
61.4		 5mieA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA601_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 HIS A 111
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 0.24A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		5 / 5 HIS A  64
HIS A  66
TRP A 107
HIS A 109
HIS A 453
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1500 (-4.2A)
CU  A1500 (-3.3A)
CU  A1500 (-3.4A)
 0.19A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 399
HIS A 401
HIS A 451
HIS A 111
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
CU  A1501 (-3.3A)
 0.69A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 HIS A 453
HIS A 399
HIS A 451
HIS A 401
 CU  A1500 (-3.4A)
CU  A1502 (-2.9A)
CU  A1501 (-2.9A)
CU  A1501 ( 3.2A)
 0.90A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A  64
HIS A  66
HIS A 399
HIS A 401
 CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
 0.17A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 111
HIS A  64
HIS A 401
HIS A 451
 CU  A1501 (-3.3A)
CU  A1502 (-3.2A)
CU  A1501 ( 3.2A)
CU  A1501 (-2.9A)
 1.30A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 399
HIS A 401
HIS A  64
HIS A  66
 CU  A1502 (-2.9A)
CU  A1501 ( 3.2A)
CU  A1502 (-3.2A)
CU  A1500 ( 2.9A)
 0.78A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA604_0
(LACCASE 2)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 HIS A 396
CYH A 452
ILE A 454
HIS A 457
 CU  A1503 (-3.2A)
CU  A1503 (-2.1A)
CU  A1503 (-3.4A)
CU  A1503 (-3.2A)
 0.23A 5migA-1v10A:
61.4		 5migA-1v10A:
57.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NNW_D_GCSD302_1
(25 KDA PROTEIN
ELICITOR)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 7 ASP A 229
GLY A 230
HIS A 399
ASN A 404
 None
None
CU  A1502 (-2.9A)
None
 1.00A 5nnwD-1v10A:
undetectable		 5nnwD-1v10A:
10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NNW_D_GCSD302_1
(25 KDA PROTEIN
ELICITOR)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 7 GLY A 246
HIS A 453
ASP A 455
HIS A  64
 None
CU  A1500 (-3.4A)
None
CU  A1502 (-3.2A)
 1.04A 5nnwD-1v10A:
undetectable		 5nnwD-1v10A:
10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NO9_D_95ZD302_1
(25 KDA PROTEIN
ELICITOR)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 7 ASP A 229
GLY A 230
HIS A 399
ASN A 404
 None
None
CU  A1502 (-2.9A)
None
 1.02A 5no9D-1v10A:
undetectable		 5no9D-1v10A:
10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NO9_D_95ZD302_1
(25 KDA PROTEIN
ELICITOR)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 7 GLY A 246
HIS A 453
ASP A 455
HIS A  64
 None
CU  A1500 (-3.4A)
None
CU  A1502 (-3.2A)
 1.09A 5no9D-1v10A:
undetectable		 5no9D-1v10A:
10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OTR_A_ACTA402_0
(CASEIN KINASE II
SUBUNIT ALPHA)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 5 VAL A 126
ASP A 128
PRO A 129
ALA A 103
 None
 0.86A 5otrA-1v10A:
undetectable		 5otrA-1v10A:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_A_PCFA1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 7 VAL A 407
ILE A 310
SER A 413
THR A 410
 None
 0.98A 5vkqA-1v10A:
0.0
5vkqD-1v10A:
undetectable		 5vkqA-1v10A:
14.62
5vkqD-1v10A:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_B_PCFB1802_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 7 SER A 413
THR A 410
VAL A 407
ILE A 310
 None
 1.01A 5vkqA-1v10A:
undetectable
5vkqB-1v10A:
undetectable		 5vkqA-1v10A:
14.62
5vkqB-1v10A:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_D_PCFD1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 7 SER A 413
THR A 410
VAL A 407
ILE A 310
 None
 0.99A 5vkqC-1v10A:
undetectable
5vkqD-1v10A:
undetectable		 5vkqC-1v10A:
14.62
5vkqD-1v10A:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CK2_C_IPHC101_0
(INSULIN A CHAIN
INSULIN B CHAIN)		 1v10 LACCASE
(Rigidoporus
microporus) 		4 / 4 ILE A  87
LEU A 120
HIS A   8
ALA A  27
 None
 0.85A 6ck2C-1v10A:
undetectable
6ck2D-1v10A:
undetectable		 6ck2C-1v10A:
3.97
6ck2D-1v10A:
5.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
7DFR_A_FOLA161_1
(DIHYDROFOLATE
REDUCTASE)		 1v10 LACCASE
(Rigidoporus
microporus) 		3 / 3 ASP A 131
LEU A 134
ARG A 200
 None
 0.65A 7dfrA-1v10A:
undetectable		 7dfrA-1v10A:
14.99